Alloy Therapeutics, Proactive and LoQus23 Therapeutics have all agreed to take new space at BioMed Realty’s McClintock ...

You may not recall the one-off 500,000th example of the G-Class that Mercedes dressed up to look like an original 280 GE when ...

Get all latest & breaking news on Balasore Alloys. Watch videos, top stories and articles on Balasore Alloys at moneycontrol.com.

The Series B round was co-led by Samsara BioCapital and Enavate Sciences, with participation from Pfizer Ventures ... supported by its collaboration with Alloy Therapeutics to develop precision ...

With a forward P/E ratio of 5.79 and a PEG ratio of 0.05, BioNTech played a huge part in formulating the BioNTech-Pfizer vaccine ... supplies ferro-alloys; along with processes ferrous and ...

Pfizer decided to discontinue the development of its leading weight management candidate. Despite this setback, the company has a deep pipeline of candidates, especially in oncology. Pfizer's ...

Pfizer has axed its oral GLP-1 asset danuglipron after one patient had potential drug-induced liver injury in a phase 1 trial. The setback blows a hole in the Big Pharma’s plans to challenge for ...

Pfizer discontinues danuglipron after liver injury in trial patient Lilly and Novo Nordisk shares rise after Pfizer's decision Pfizer to focus on other obesity research April 14 (Reuters) - Pfizer ...

Pfizer is halting development of its experimental weight-loss pill, as the booming obesity drug market remains out of reach for the drug giant. The company said Monday the stoppage comes after it ...